new zealand hospices turn away dying patients funding gap

The article describes a funding gap in New Zealand's hospice sector, leading to reduced capacity for end-of-life care. The commercial mechanism is weak: it is a public healthcare funding issue with no direct commodity, supply chain, or corporate margin impact. The primary effect is on public health system strain, not on traded goods or private sector revenues. No specific company, product, or input scarcity is identified. Relevant sectors are limited to healthcare, but the mechanism is not commercially material for investors.